Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,329 public trials 916 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Recruiting

TheraSphere Japan Pre-Market Study

NCT07377487

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations
  • Hyogo College of Medicine Hospital Nishinomiya, Hyōgo, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • Kindai University Hospital Sayama, Osaka, Japan
  • National Cancer Center Hospital Chuo Ku, Tokyo, Japan
View Trial Details
Recruiting

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

NCT06820463

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • City of Hope National Medical Center /ID# 270255 Duarte, California, United States
  • UCLA - Santa Monica /ID# 270621 Santa Monica, California, United States
  • Yale New Haven Hospital /ID# 270565 New Haven, Connecticut, United States
  • University of Chicago Medical Center /ID# 271688 Chicago, Illinois, United States
View all 73 locations
View Trial Details
Recruiting

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

NCT05379595

Conditions
Advanced or Metastatic Colorectal Cancer, Colonic Diseases, Colorectal Neoplasms, +9 more
Locations
  • O Neal Comprehensive Cancer Center at UAB Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of California, Los Angeles UCLA Los Angeles, California, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 53 locations
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

NCT06004245

Conditions
Advanced Solid Tumors, Colonic Diseases, Colorectal Cancer, +14 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • START Los Angeles Los Angeles, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

NCT07468071

Conditions
Advanced Solid Tumors Harboring the KRAS G12C Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Koto Ku, Tokyo, Japan
View all 21 locations
View Trial Details
Recruiting

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07229313

Conditions
Adnexal Diseases, Advance Solid Tumors, Breast Diseases, +59 more
Locations
  • Kivu Trial Site Santa Monica, California, United States
  • Kivu Trial Site Camperdown, New South Wales, Australia
  • Kivu Trial Site Sydney, New South Wales, Australia
  • Kivu Trial Site Brisbane, Queensland, Australia
View Trial Details

Related conditions